Md. Takdir Hossain | Pharmacy | Best Researcher Award

Mr. Md. Takdir Hossain | Pharmacy | Best Researcher Award

Mr. Md. Takdir Hossain | Pharmacy | Department of Pharmacy at Gopalganj Science & Technology University | Bangladesh

Mr. Md. Takdir Hossain is an emerging pharmaceutical researcher and academician from the Department of Pharmacy, Gopalganj Science & Technology University (GSTU), Dhaka, Bangladesh, recognized for his exceptional dedication to the fields of pharmacology, drug discovery, and natural product research. He holds both a Bachelor of Pharmacy (B.Pharm) and a Master of Pharmacy (M.Pharm) with thesis from GSTU, graduating with distinction and securing top ranks in his cohort. His educational journey reflects a deep commitment to academic excellence and scientific innovation, demonstrated through his consistent research performance and analytical abilities. Professionally, Mr. Hossain is a registered A-Grade Pharmacist (Reg. No: A-23380) and has contributed to multiple experimental and computational projects focusing on anticancer, anti-inflammatory, antidiabetic, antioxidant, and antidepressant activities of natural plant extracts. His research experience spans in-vivo, in-vitro, and in-silico investigations, with a special emphasis on exploring bioactive compounds from medicinal plants for potential therapeutic applications. Mr. Md. Takdir Hossain has gained advanced knowledge through specialized international coursework from prestigious institutions such as Johns Hopkins University, Yale University, Duke University, and the University of Pennsylvania, excelling in oncology, physiology, and biochemistry. His research interests include molecular pharmacology, computational drug design, and phytochemistry, particularly focusing on mechanistic studies of anticancer and anti-inflammatory agents. His research skills encompass molecular docking, pharmacological data interpretation, literature synthesis, and experimental pharmacodynamics. Throughout his academic and research journey, he has received numerous distinctions, including high rankings in national-level entrance examinations and recognition for academic merit and innovation in pharmaceutical sciences. Mr. Md. Takdir Hossain continues to demonstrate exceptional potential as a future leader in pharmaceutical and biomedical research. His interdisciplinary approach, combined with a strong foundation in both experimental and computational methods, positions him as a promising contributor to global health research. His ongoing efforts in drug development and natural product pharmacology underscore his dedication to advancing medical science and promoting evidence-based therapeutic innovations.

Profile: ORCID

Featured Publications 

  1. Hossain, M. T. (2025). Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights. Drug Development Research.  Citations: 15

  2. Hossain, M. T. (2025). Assessment of the Anticancer Activity of Aegle marmelos Leaf Extracts Against Ehrlich’s Ascites Carcinoma (EAC) Cell Line in Swiss Albino Mice. Journal of Phytochemical Insights. Citations: 12

  3. Hossain, M. T. (2025). Anti-Inflammatory Therapeutic Potential of 6,8,10-Gingerols Against Cox Pathway by Molecular Docking Analysis. Preprints. Citations: 9

  4. Hossain, M. T. (2025). Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes. European Journal of Pharmacology. Citations: 18

  5. Hossain, M. T. (2024). Computational Evaluation of Natural Phytochemicals as Novel Inhibitors of EGFR in Cancer Therapy. Asian Journal of Pharmaceutical Sciences. — Citations: 22

  6. Hossain, M. T. (2024). In-Vivo and In-Silico Studies on the Antioxidant and Neuroprotective Effects of Medicinal Plant Extracts. BMC Complementary Medicine and Therapies. — Citations: 14

  7. Hossain, M. T. (2024). Phytochemical and Pharmacological Assessment of Medicinal Plants for Diabetes and Inflammation Management. Frontiers in Pharmacology. — Citations: 11

Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Dr. Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Senior Clinical Pharmacist | Beni-Suef University Hospital | Egypt

👩‍🔬 Short Bio:

Selvia Maher Farag Hanna is a dedicated Senior Clinical Pharmacist and Member of the Clinical Research Center at Beni-Suef University Hospital, specializing in Cardiology. With 12 years of experience, she excels in medication therapy management and improving patient outcomes through interdisciplinary collaboration.

Profile:

SCOPUS

📚 Education:

Selvia completed her Doctor of Philosophy in Pharmaceutical Sciences (Clinical Pharmacy) at Beni-Suef University in July 2024. She holds a Master’s degree in Pharmaceutical Sciences (Clinical Pharmacy) and a Bachelor’s degree in Pharmaceutical Sciences, both from Beni-Suef University.

💼 Experience:

Since July 2012, Selvia has served as a Clinical Pharmacist at Beni-Suef University Hospital, focusing on medication management in the Cardiology care unit. Previously, she worked at El-Masrya Pharmacy, gaining experience in medication counseling and drug utilization review.

🔬 Research Interest:

Selvia’s research interests revolve around Cardiology, specifically hypertension management, drug interactions, and patient-centric care strategies to enhance treatment efficacy and safety.

🏆 Award:

Recipient of the Distinguished Scientist Award for her contributions to Clinical Pharmacy and Cardiology research.

📄 Publications:

  1. Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure
    Published in High Blood Pressure & Cardiovascular Prevention, November 2018.
    View Publication
    Cited 11 times.
  2. Effect of Fixed-dose Combination Amlodipine/Valsartan in Comparison to Two Drug Combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure
    Published in Current Hypertension Reviews, May 2023.
    View Publication
  3. Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
    Published in Current Hypertension Reviews, September 2022.
  4. Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure
    Published in Hipertension y Riesgo Vascular, January–March 2024.